Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

02-06-2015 | Original Paper

Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale

Auteurs: Carly J. Johnco, Alessandro S. De Nadai, Adam B. Lewin, Jill Ehrenreich-May, Jeffrey J. Wood, Eric A. Storch

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 10/2015

Abstract

This study examined optimal guidelines to assess treatment response and remission for anxiety in youth with autism spectrum disorders (ASD) using the Pediatric Anxiety Rating Scale (PARS). Data was collected for 108 children aged 7–16 years with comorbid anxiety and ASD before and after receiving cognitive behavior therapy. Optimal cut-offs on the PARS were assessed using signal detection analyses using receiver operating characteristic methods. Maximum agreement with response criteria was achieved at 15 % reduction in symptoms on the PARS. Maximum agreement with remission criteria was achieved at 40 % reduction in symptoms, or at a score of 10 or below at post-treatment. Results have implications for standardizing criteria used in research trials and clinical practice.

vorige artikel Reliability and Validity of Parent- and Child-Rated Anxiety Measures in Autism Spectrum Disorder

volgende artikel Erratum to: Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed.). Washington, DC: Author.

Bandelow, B. (2006). Defining response and remission in anxiety disorders: Toward an integrated approach. CNS Spectrums, 11(10 Suppl 12), 21–28.PubMed

Caporino, N. E., Brodman, D. M., Kendall, P. C., Albano, A. M., Sherrill, J., Piacentini, J., et al. (2013). Defining treatment response and remission in child anxiety: Signal detection analysis using the Pediatric Anxiety Rating Scale. Journal of the American Academy of Child and Adolescent Psychiatry, 52(1), 57–67.PubMedCentralCrossRefPubMed

Chalfant, A. M., Rapee, R. M., & Carroll, L. (2007). Treating anxiety disorders in children with high functioning autism spectrum disorders: A controlled trial. Journal of Autism and Developmental Disorders, 37(10), 1842–1857. doi:10.1007/s10803-006-0318-4.CrossRefPubMed

Ehrenreich-May, J., Storch, E. A., Queen, A. H., Hernandez Rodriguez, J., Ghilain, C. S., Alessandri, M., et al. (2014). An open trial of cognitive-behavioral therapy for anxiety disorders in adolescents with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities, 29(3), 145–155. doi:10.1177/1088357614533381.CrossRef

Farris, S. G., McLean, C. P., Van Meter, P. E., Simpson, H. B., & Foa, E. B. (2013). Treatment response, symptom remission, and wellness in obsessive–compulsive disorder. Journal of Clinical Psychiatry, 74(7), 685–690. doi:10.4088/JCP.12m07789.PubMedCentralCrossRefPubMed

Ginsburg, G. S., Keeton, C. P., Drazdowski, T. K., & Riddle, M. A. (2011). The utility of clinicians ratings of anxiety using the Pediatric Anxiety Rating Scale (PARS). Child & Youth Care Forum, 40(2), 93–105. doi:10.1007/s10566-010-9125-3.CrossRef

Guy, W. (1976). Clinical global impressions ECDEU assessment manual for psychopharmacology. Rockville, MD: National Institute for Mental Health.

Jeon, S., Walkup, J. T., Woods, D. W., Peterson, A., Piacentini, J., Wilhelm, S., et al. (2013). Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods. Contemporary Clinical Trials, 36(2), 414–420. doi:10.1016/j.cct.2013.08.012.PubMedCentralCrossRefPubMed

Kerns, C. M., & Kendall, P. C. (2012). The presentation and classification of anxiety in autism spectrum disorder. Clinical Psychology: Science and Practice, 19(4), 323–347. doi:10.1111/cpsp.12009.

Kerns, C. M., Kendall, P. C., Berry, L., Souders, M. C., Franklin, M. E., Schultz, R. T., et al. (2014). Traditional and atypical presentations of anxiety in youth with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(11), 2851–2861. doi:10.1007/s10803-014-2141-7.CrossRefPubMed

Kerns, C. M., Maddox, B. B., Kendall, P. C., Rump, K., Berry, L., Schultz, R. T., et al. (2015). Brief measures of anxiety in non-treatment-seeking youth with autism spectrum disorder. Autism,. doi:10.1177/1362361314558465.

Kraemer, H. C., Kupfer, D. J., Clarke, D. E., Narrow, W. E., & Regier, D. A. (2012). DSM-5: How reliable is reliable enough? American Journal of Psychiatry, 169(1), 13–15. doi:10.1176/appi.ajp.2011.11010050.CrossRefPubMed

Kraemer, H. C., Periyakoil, V. S., & Noda, A. (2002). Kappa coefficients in medical research. Statistics in Medicine, 21(14), 2109–2129. doi:10.1002/sim.1180.CrossRef

Leckman, J. F., Riddle, M. A., Hardin, M. T., Ort, S. I., Swartz, K. L., Stevenson, J., et al. (1989). The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. Journal of the American Academy of Child and Adolescent Psychiatry, 28(4), 566–573. doi:10.1097/00004583-198907000-00015.CrossRefPubMed

Lewin, A. B., De Nadai, A. S., Park, J. M., Goodman, W. K., Murphy, T. K., & Storch, E. A. (2011). Refining clinical judgment of treatment outcome in obsessive–compulsive disorder. Psychiatry Research, 185, 394–401.CrossRefPubMed

Lewin, A. B., & Storch, E. A. (2014). Unpublished data.

Lord, C., Rutter, M., DiLavore, P. C., & Risi, S. (1999). Autism diagnostic observation schedule. Los Angeles: Western Psychological Services.

Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24(5), 659–685.CrossRefPubMed

McNally Keehn, R. H., Lincoln, A. J., Brown, M. Z., & Chavira, D. A. (2013). The coping cat program for children with anxiety and autism spectrum disorder: A pilot randomized controlled trial. Journal of Autism and Developmental Disorders, 43(1), 57–67. doi:10.1007/s10803-012-1541-9.PubMedCentralCrossRefPubMed

Reaven, J. A., Blakeley-Smith, A., Culhane-Shelburne, K., & Hepburn, S. (2012). Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: A randomized trial. Journal of Child Psychology and Psychiatry, 53(4), 410–419. doi:10.1111/j.1469-7610.2011.02486.x.PubMedCentralCrossRefPubMed

Rudy, B. M., Lewin, A. B., & Storch, E. A. (2013). Managing anxiety comorbidity in youth with autism spectrum disorders. Neuropsychiatry, 3(4), 411–421. doi:10.2217/npy.13.53.CrossRef

RUPP. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The New England Journal of Medicine, 344(17), 1279–1285. doi:10.1056/NEJM200104263441703.CrossRef

RUPP. (2002). The Pediatric Anxiety Rating Scale (PARS): Development and psychometric properties. Journal of the American Academy of Child and Adolescent Psychiatry, 41(9), 1061–1069. doi:10.1097/00004583-200209000-00006.CrossRef

Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). Children’s Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 844–852. doi:10.1097/00004583-199706000-00023.CrossRefPubMed

Silverman, W. K., & Albano, A. M. (1996). The anxiety disorders interview schedule for DSM-IV–child and parent versions. London, England: Oxford University Press.

Steele, M., Jensen, P. S., & Quinn, D. M. (2006). Remission versus response as the goal of therapy in ADHD: A new standard for the field? Clinical Therapeutics, 28(11), 1892–1908. doi:10.1016/j.clinthera.2006.11.006.CrossRefPubMed

Storch, E. A., Arnold, E. B., Lewin, A. B., Nadeau, J. M., Jones, A. M., De Nadai, A. S., et al. (2013). The effect of cognitive-behavioral therapy versus treatment as usual for anxiety in children with autism spectrum disorders: a randomized, controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 52(2), 132–142.e132, doi:10.1016/j.jaac.2012.11.007.

Storch, E. A., De Nadai, A. S., Lewin, A. B., McGuire, J. F., Jones, A. M., Mutch, P. J., et al. (2011). Defining treatment response in pediatric tic disorders: A signal detection analysis of the Yale Global Tic Severity Scale. Journal of Child and Adolescent Psychopharmacology, 21(6), 621–627. doi:10.1089/cap.2010.0149.PubMedCentralCrossRefPubMed

Storch, E. A., Ehrenreich-May, J., Wood, J. J., Jones, A. M., De Nadai, A. S., Lewin, A. B., et al. (2012a). Multiple informant agreement on the anxiety disorders interview schedule in youth with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 22(4), 292–299. doi:10.1089/cap.2011.0114.PubMedCentralCrossRefPubMed

Storch, E. A., Lewin, A. B., Collier, A. B., Arnold, E., De Nadai, A. S., Dane, B. F., et al. (2014). A randomized controlled trial of cognitive-behavioral therapy versus treatment as usual for adolescents with autism spectrum disorders and comorbid anxiety. Depression and Anxiety, 32(3), 174–181. doi:10.1002/da.22332.CrossRefPubMed

Storch, E. A., Lewin, A. B., De Nadai, A. S., & Murphy, T. K. (2010). Defining treatment response and remission in obsessive–compulsive disorder: A signal detection analysis of the children’s yale-brown obsessive compulsive scale. Journal of the American Academy of Child and Adolescent Psychiatry, 49(7), 708–717. doi:10.1016/j.jaac.2010.04.005.PubMed

Storch, E. A., Wood, J. J., Ehrenreich-May, J., Jones, A. M., Park, J. M., Lewin, A. B., et al. (2012b). Convergent and discriminant validity and reliability of the pediatric anxiety rating scale in youth with autism spectrum disorders. Journal of Autism and Developmental Disorders, 42(11), 2374–2382. doi:10.1007/s10803-012-1489-9.CrossRefPubMed

Sukhodolsky, D. G., Bloch, M. H., Panza, K. E., & Reichow, B. (2013). Cognitive-behavioral therapy for anxiety in children with high-functioning autism: A meta-analysis. [Meta Analysis]. Pediatrics, 132(5), e1341–e1350. doi:10.1542/peds.2013-1193.PubMedCentralCrossRefPubMed

Tolin, D. F., Abramowitz, J. S., & Diefenbach, G. J. (2005). Defining response in clinical trials for obsessive–compulsive disorder: A signal detection analysis of the Yale-Brown obsessive compulsive scale. Journal of Clinical Psychiatry, 66(12), 1549–1557.CrossRefPubMed

Ung, D., Arnold, E., De Nadai, A., Lewin, A., Phares, V., Murphy, T., et al. (2014). Inter-rater reliability of the anxiety disorders interview schedule for DSM-IV in high-functioning youth with autism spectrum disorder. Journal of Developmental and Physical Disabilities, 26(1), 53–65. doi:10.1007/s10882-013-9343-3.PubMedCentralCrossRefPubMed

Vasa, R. A., Carroll, L. M., Nozzolillo, A. A., Mahajan, R., Mazurek, M. O., Bennett, A. E., et al. (2014). A Systematic Review of Treatments for Anxiety in Youth with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders, 1–15, doi:10.1007/s10803-014-2184-9.

Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766. doi:10.1056/NEJMoa0804633.PubMedCentralCrossRefPubMed

White, S. W., Ollendick, T., Albano, A. M., Oswald, D., Johnson, C., Southam-Gerow, M. A., et al. (2013). Randomized controlled trial: multimodal anxiety and social skill intervention for adolescents with autism spectrum disorder. Journal of Autism and Developmental Disorders, 43(2), 382–394. doi:10.1007/s10803-012-1577-x.PubMedCentralCrossRefPubMed

Williams, K., Wheeler, D. M., Silove, N., & Hazell, P. (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Systematic Review, 8, CD004677. doi:10.1002/14651858.CD004677.pub2.

Wood, J. J., & Drahota, A. (2005). Behavioral interventions for anxiety in children with autism. Los Angeles, CA: University of California-Los Angeles.

Wood, J. J., Ehrenreich-May, J., Alessandri, M., Fujii, C., Renno, P., Laugeson, E., et al. (2015). Cognitive behavioral therapy for early adolescents with autism spectrum disorders and clinical anxiety: A randomized, controlled trial. Behavior Therapy, 46(1), 7–19. doi:10.1016/j.beth.2014.01.002.CrossRefPubMed

Titel: Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale
Auteurs: Carly J. Johnco
Alessandro S. De Nadai
Adam B. Lewin
Jill Ehrenreich-May
Jeffrey J. Wood
Eric A. Storch
Publicatiedatum: 02-06-2015
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 10/2015
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-015-2483-9

Andere artikelen Uitgave 10/2015

The Effect of Visual Perceptual Load on Auditory Awareness in Autism Spectrum Disorder

Original Paper

Brief Report: Systematic Review of Rett Syndrome in Males

Brief Report

Gender Differences in Vocational Rehabilitation Service Predictors of Successful Competitive Employment for Transition-Aged Individuals with Autism

Original Paper

The Association Between Autism Spectrum Disorders and Congenital Anomalies by Organ Systems in a Finnish National Birth Cohort

Original Paper

Erratum to: Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale

Erratum

Stop and Change: Inhibition and Flexibility Skills Are Related to Repetitive Behavior in Children and Young Adults with Autism Spectrum Disorders

Open Access
Original Paper